Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decarboxylase inhibitors.

× No keyword cloud information.

14 in total

1. Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors: E E Müller
Journal: Acta Neurochir (Wien) Date: 1985 Impact factor: 2.216

2. Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings].

Authors: M J Jung; M G Palfreyman; G Ribereau-Gayon; J Wagner; M Zraïka
Journal: Br J Pharmacol Date: 1979-11 Impact factor: 8.739

3. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.

Authors: F J Miñano; R D Myers
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

4. In vivo effects of new inhibitors of catechol-O-methyl transferase.

Authors: E Rivas; M L de Ceballos; O Nieto; J A Fontenla
Journal: Br J Pharmacol Date: 1999-04 Impact factor: 8.739

5. Further studies on the inhibition of monoamine synthesis by monofluoromethyldopa.

Authors: P Bey; M J Jung; J Koch-Weser; M G Palfreyman; A Sjoerdsma; J Wagner; M Zraïka
Journal: Br J Pharmacol Date: 1980-12 Impact factor: 8.739

Review 6. The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors: M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal: Experientia Date: 1984-11-15

7. Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.

Authors: Ki Sung Kang; Noriko Yamabe; Yujing Wen; Masayuki Fukui; Bao Ting Zhu
Journal: Brain Res Date: 2012-12-01 Impact factor: 3.252

8. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.

Authors: A Martinez-Campos; P Giovannini; E Parati; A Novelli; T Caraceni; E E Müller
Journal: J Neurol Neurosurg Psychiatry Date: 1981-12 Impact factor: 10.154

9. Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.

Authors: P Johansson; M Henning
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1982-10 Impact factor: 3.000

Review 10. Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors: E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal: Drugs Date: 1983-04 Impact factor: 9.546